Active: Mol Neurodegener Clear all

GWAS 2024-01-03

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.

Wang L, Nykänen NP et al.

Mol Neurodegener

Triggering receptor expressed on myeloid cells 2 (TREM2) plays a critical role in microglial activat...

Cerebrospinal fluid soluble TREM2 levels

3350

Participants

N/A

Studies

Details PubMed

GWAS 2023-06-22

A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.

Kang M, Ang TFA et al.

Mol Neurodegener

More than 75 common variant loci account for only a portion of the heritability for Alzheimer's dise...

Cognitive domain scores for memory

103796

Participants

N/A

Studies

Details PubMed

GWAS 2018-08-08

Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.

Chen JA, Chen Z et al.

Mol Neurodegener

Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease for which the genetic contr...

Progressive supranuclear palsy

12308

Participants

N/A

Studies

Details PubMed

Title

Author

Journal

Disease/Trait

Date

Actions

Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.

Wang L, Nykänen NP et al.

Mol Neurodegener

Cerebrospinal fluid soluble TREM2 levels

2024-01-03

A genome-wide search for pleiotropy in more than 100,000 harmonized longitudinal cognitive domain scores.

Kang M, Ang TFA et al.

Mol Neurodegener

Cognitive domain scores for memory

2023-06-22

Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases.

Chen JA, Chen Z et al.

Mol Neurodegener

Progressive supranuclear palsy

2018-08-08